Molina Healthcare (NYSE:MOH) Earns “Equal Weight” Rating from Stephens

Stephens restated their equal weight rating on shares of Molina Healthcare (NYSE:MOH) in a research note published on Thursday morning, Benzinga reports. The firm currently has a $390.00 target price on the stock.

Several other analysts also recently commented on MOH. StockNews.com downgraded shares of Molina Healthcare from a strong-buy rating to a buy rating in a report on Thursday, February 8th. Barclays started coverage on shares of Molina Healthcare in a report on Wednesday, March 6th. They issued an equal weight rating and a $437.00 target price for the company. Cantor Fitzgerald reiterated an overweight rating and issued a $406.00 target price on shares of Molina Healthcare in a report on Thursday, April 4th. Bank of America downgraded shares of Molina Healthcare from a neutral rating to an underperform rating and set a $439.00 target price for the company. in a report on Thursday, March 28th. Finally, Truist Financial increased their target price on shares of Molina Healthcare from $435.00 to $460.00 and gave the company a buy rating in a report on Tuesday, February 20th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, Molina Healthcare has a consensus rating of Hold and an average target price of $396.09.

Molina Healthcare Stock Performance

MOH opened at $342.23 on Thursday. The company has a current ratio of 1.49, a quick ratio of 1.54 and a debt-to-equity ratio of 0.53. The company’s fifty day moving average price is $390.34 and its two-hundred day moving average price is $372.12. Molina Healthcare has a 1-year low of $266.35 and a 1-year high of $423.92. The company has a market cap of $20.05 billion, a price-to-earnings ratio of 18.57, a PEG ratio of 0.96 and a beta of 0.47.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, April 24th. The company reported $5.73 earnings per share for the quarter, topping the consensus estimate of $5.46 by $0.27. Molina Healthcare had a net margin of 2.99% and a return on equity of 29.86%. The firm had revenue of $9.93 billion for the quarter, compared to the consensus estimate of $9.45 billion. During the same quarter in the prior year, the company posted $5.81 earnings per share. The business’s revenue was up 21.9% on a year-over-year basis. On average, analysts expect that Molina Healthcare will post 23.62 EPS for the current fiscal year.

Insider Buying and Selling

In related news, CFO Mark Lowell Keim sold 15,000 shares of the firm’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the completion of the sale, the chief financial officer now owns 36,531 shares in the company, valued at $14,121,423.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other Molina Healthcare news, Director Richard M. Schapiro sold 1,000 shares of the stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $401.05, for a total transaction of $401,050.00. Following the completion of the transaction, the director now owns 11,207 shares in the company, valued at $4,494,567.35. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Mark Lowell Keim sold 15,000 shares of the stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $386.56, for a total transaction of $5,798,400.00. Following the transaction, the chief financial officer now owns 36,531 shares of the company’s stock, valued at approximately $14,121,423.36. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 16,711 shares of company stock worth $6,472,517. Insiders own 1.10% of the company’s stock.

Hedge Funds Weigh In On Molina Healthcare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in MOH. Norges Bank bought a new position in Molina Healthcare during the fourth quarter worth about $275,143,000. Wellington Management Group LLP boosted its position in shares of Molina Healthcare by 12.8% in the fourth quarter. Wellington Management Group LLP now owns 3,831,100 shares of the company’s stock valued at $1,384,215,000 after acquiring an additional 436,060 shares during the period. Capital Research Global Investors boosted its position in shares of Molina Healthcare by 5.4% in the fourth quarter. Capital Research Global Investors now owns 2,430,283 shares of the company’s stock valued at $878,086,000 after acquiring an additional 123,894 shares during the period. California Public Employees Retirement System boosted its position in shares of Molina Healthcare by 53.0% in the third quarter. California Public Employees Retirement System now owns 331,652 shares of the company’s stock valued at $108,745,000 after acquiring an additional 114,890 shares during the period. Finally, Invesco Ltd. boosted its position in shares of Molina Healthcare by 10.4% in the third quarter. Invesco Ltd. now owns 1,190,161 shares of the company’s stock valued at $390,242,000 after acquiring an additional 112,243 shares during the period. Institutional investors own 98.50% of the company’s stock.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.